(Q81099029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Andersen RS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Wenandy L

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sørensen RB

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

thor Straten P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Andersen MH

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

6 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

668-669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805325%20AND%20SRC:MED&resulttype=core&format=json

Part II: Vaccines for haematological malignant disorders.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

Regulators of apoptosis: suitable targets for immune therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

Identification of an HLA-A1 restricted CTL epitope from Mcl-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

Functional capacity of Mcl-1-specific cytotoxic T-cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021

Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404937

7 January 2021